Sigma Healthcare Withdraws From $10 Billion Boots Sale Process
Updated
Updated · Bloomberg · Jun 15
Sigma Healthcare Withdraws From $10 Billion Boots Sale Process
3 articles · Updated · Bloomberg · Jun 15
Summary
Sigma Healthcare said Monday it has withdrawn from the sale process for Boots and ended discussions immediately.
The exit removes one of the parties that had been exploring a potential acquisition of the British pharmacy chain in a deal valued at as much as $10 billion.
Sigma gave no reason for the decision in its statement, leaving the status of other bidders and the wider sale process unclear.